'Cures' Act in Congress Heavily Influenced by Lobb
Post# of 72435
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
"AbbVie, the maker of Humira, a drug used to treat arthritis, ulcerative colitis and Crohn's disease, reported $7.7 million in lobbying expenditures in disclosures listing the bill as an issue. The company's total lobbying was $9.5 million this cycle."
Interesting...
http://www.nbcnews.com/health/health-news/cur...ts-n689531
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)